Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BK virus infection in de novo kidney transplant recipients receiving mizoribine versus mycophenolic acid
ChiCTR-IPR-16009202Phase 4Recruiting
- Sponsor
- Beijing Friendship Hospital
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in kidney transplant comparing MZR group with MMF/EC-MPS group (2 arms). Primary endpoints: BK virus, BK viruria and 2 more. Started Sep 2016; status: recruiting.
02
Drugs
mizoribinemycophenolic acid
03
Conditions
kidney transplant
Beyond the preview
Go deeper on ChiCTR-IPR-16009202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009202.